OneFund LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

OneFund LLC’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$313K	Sell	699 -35	-5%	-$16.3K	0.2%	92
2025 Q4	$333K	Buy	734 +39	+6%	+$16.8K	0.2%	92
2025 Q3	$272K	Buy	695 +27	+4%	+$11.3K	0.18%	104
2025 Q2	$297K	Sell	668 -9	-1%	-$4.15K	0.21%	93
2025 Q1	$328K	Sell	677 -8	-1%	-$3.73K	0.33%	78
2024 Q4	$276K	Buy	685 +5	+0.7%	+$2.32K	0.26%	90
2024 Q3	$316K	Buy	680 +5	+0.7%	+$2.4K	0.32%	77
2024 Q2	$316K	Buy	675 +6	+0.9%	+$2.6K	0.34%	77
2024 Q1	$281K	Sell	669 -14	-2%	-$5.92K	0.34%	82
2023 Q4	$278K	Buy	+683	New	+$252K	0.36%	80

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OneFund LLC's VRTX Position: Q1 2026 in Review

OneFund LLC reduced its Vertex Pharmaceuticals (VRTX) stake by 4.8% in Q1 2026, selling an estimated $16.3K and leaving 699 shares worth $313K. The position accounts for 0.2% of the portfolio, ranked #92.

OneFund LLC first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $333K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

OneFund LLC held 699 shares of Vertex Pharmaceuticals worth $313K as of Q1 2026.
OneFund LLC sold 35 Vertex Pharmaceuticals shares in Q1 2026, an estimated $16.3K.
Vertex Pharmaceuticals made up 0.2% of OneFund LLC's portfolio in Q1 2026, its #92 holding.
OneFund LLC first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
OneFund LLC's Vertex Pharmaceuticals position peaked at $333K in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.